Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department plans make an assessment of the use of (a) fibrous forms of talc, (b) tremolite and (c) actinolite in products used by the NHS.

From a medicines perspective, additives in medicines, termed excipients, are required to comply with the standards laid down in pharmacopeial monographs and can only be included in medicinal products at levels that are considered to be safe.

The Medicines and Healthcare products Regulatory Agency is aware of general concerns in relation to the presence of asbestos in talcum powder. However, pharmaceutical grade talc has strict controls on the presence of asbestos. The British Pharmacopeia monograph for Purified Talc states that “Talc derived from deposits that are known to contain associated asbestos is not suitable for pharmaceutical use”. Furthermore, testing is required to confirm the absence of asbestos.

NHS Supply Chain procurement activities require suppliers to comply with United Kingdom regulatory requirements such as the United Kingdom Accreditation Service or international equivalent accreditation for International Organization for Standardization (ISO) 9001 and ISO 13485, to ensure that products procured under NHS Supply Chain frameworks and used within the National Health Service in England are subject to rigorous safety assessments.